Current Status of Biomarkers and Molecular Diagnostic Tools for Rejection in Liver Transplantation: Light at the End of the Tunnel?

Shimamura, 2022, Liver transplantation for hepatocellular carcinoma: how should we improve the thresholds?, Cancers, 14, 419, 10.3390/cancers14020419 OTPN/SRTR Levitsky, 2016, Acute rejection increases risk of graft failure and death in recent liver transplant recipients, Clin Gastroenterol Hepatol, 15, 584, 10.1016/j.cgh.2016.07.035 Krenzien, 2019, Diagnostic biomarkers to diagnose acute allograft rejection after liver transplantation: systematic review and meta-analysis of diagnostic accuracy studies, Front Immunol, 10, 758, 10.3389/fimmu.2019.00758 Sánchez–Fueyo, 2011, Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs, Gastroenterology, 140, 51, 10.1053/j.gastro.2010.10.059 Moini, 2015, Review on immunosuppression in liver transplantation, World J Hepatol, 7, 1355, 10.4254/wjh.v7.i10.1355 Charlton, 2018, International liver transplantation society consensus statement on immunosuppression in liver transplant recipients, Transplantation, 102, 727, 10.1097/TP.0000000000002147 Di Maira, 2020, Immunosuppression in liver transplant, Best Pract Res Clin Gastroenterol, 46–47 Watt, 2010, Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study, Am J Transplant, 10, 1420, 10.1111/j.1600-6143.2010.03126.x Azhie, 2021, Metabolic complications in liver transplantation recipients: how we can optimize long-term survival, Liver Transplant, 27, 1468, 10.1002/lt.26219 Beckebaum, 2013, Calcineurin inhibitors in liver transplantation – still champions or threatened by serious competitors?, Liver Int, 33, 656, 10.1111/liv.12133 Ziolkowski, 2003, Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity, Transplant Proc, 35, 2307, 10.1016/S0041-1345(03)00786-3 Chak, 2010, Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review: risk factors and incidence of de novo malignancy in liver transplant recipients, Liver Int, 30, 1247, 10.1111/j.1478-3231.2010.02303.x Shaked, 2019, Outcomes of immunosuppression minimization and withdrawal early after liver transplantation, Am J Transplant : Off J Am Soc Transplant Am Soc Transplant Surg, 19, 1397, 10.1111/ajt.15205 Nacif, 2015, Late acute rejection in liver transplant: a systematic review, Arq Bras Cir Dig, 28, 212, 10.1590/S0102-67202015000300017 Thurairajah, 2013, Late acute liver allograft rejection; a study of its natural history and graft survival in the current era, Transplantation, 95, 955, 10.1097/TP.0b013e3182845f6c Akamatsu, 2006, Late-onset acute rejection after living donor liver transplantation, World J Gastroenterol, 12, 6674, 10.3748/wjg.v12.i41.6674 Hutchinson, 2018, Subclinical T cell-mediated liver transplant rejection: the jury is still out, J Hepatol, 69, 570, 10.1016/j.jhep.2018.06.004 Demetris, 2016, Functional immune anatomy of the liver-as an allograft, Am J Transplant, 16, 1653, 10.1111/ajt.13749 Ronca, 2020, The immunological basis of liver allograft rejection, Front Immunol, 11, 2155, 10.3389/fimmu.2020.02155 Smyth, 2017, Continuous acquisition of MHC:peptide complexes by recipient cells contributes to the generation of anti-graft CD8(+) T cell immunity, Am J Transplant : Off J Am Soc Transplant Am Soc Transplant Surg, 17, 60, 10.1111/ajt.13996 Demetris, 2015, ABO-compatible liver allograft antibody-mediated rejection: an update, Curr Opin Organ Transplant, 20, 314, 10.1097/MOT.0000000000000194 Demetris, 2016, 2016 comprehensive update of the Banff working group on liver allograft pathology: introduction of antibody-mediated rejection, Am J Transplant, 16, 2816, 10.1111/ajt.13909 Angelico, 2021, Chronic rejection after liver transplantation: opening the Pandora's box, World J Gastroenterol, 27, 7771, 10.3748/wjg.v27.i45.7771 Blakolmer, 2000, Chronic liver allograft rejection in a population treated primarily with tacrolimus as baseline immunosuppression: long-term follow-up and evaluation of features for histopathological staging, Transplantation, 69, 2330, 10.1097/00007890-200006150-00019 Choudhary, 2017, Acute and chronic rejection after liver transplantation: what A clinician needs to know, J Clin Exp Hepatol, 7, 358, 10.1016/j.jceh.2017.10.003 Levitsky, 2016, Acute rejection increases risk of graft failure and death in recent liver transplant recipients, Clin Gastroenterol Hepatol, 15, 584, 10.1016/j.cgh.2016.07.035 Dogan, 2018, Acute allograft rejection in liver transplant recipients: incidence, risk factors, treatment success, and impact on graft failure, J Int Med Res, 46, 3979 Neuberger, 2021, The need for alternatives to liver biopsies: non-invasive analytics and diagnostics, Hepat Med, 13, 59, 10.2147/HMER.S278076 Kamali, 2021, Sensing acute cellular rejection in liver transplant patients using liver-derived extracellular particles: a prospective, observational study. Original research, Front Immunol, 12doi Califf, 2018, Biomarker definitions and their applications, Exp Biol Med (Maywood), 243, 213, 10.1177/1535370217750088 Margreiter, 1983, Neopterin as a new biochemical marker for diagnosis of allograft rejection: experience based upon evaluation of 100 consecutive cases, Transplantation, 36, 650, 10.1097/00007890-198336060-00013 Verhelst, 2013, Biomarkers for the diagnosis of acute cellular rejection in liver transplant recipients: a review: biomarkers for ACR in liver transplantation, Hepatol Res, 43, 165, 10.1111/hepr.12012 Israeli, 2008, ImmuKnow: a new parameter in immune monitoring of pediatric liver transplantation recipients, Liver Transplant, 14, 893, 10.1002/lt.21426 Rodrigo, 2012, ImmuKnow as a diagnostic tool for predicting infection and acute rejection in adult liver transplant recipients: a systematic review and meta-analysis, Liver Transplant, 18, 1244, 10.1002/lt.23497 Xiaoting, 2012, Can immune cell function assay identify patients at risk of infection or rejection? A meta-analysis, Transplantation, 93, 737, 10.1097/TP.0b013e3182466248 Duarte, 2005, Metabolic assessment of human liver transplants from biopsy samples at the donor and recipient stages using high-resolution magic angle spinning 1H NMR spectroscopy, Anal Chem, 77, 5570, 10.1021/ac050455c Cortes, 2014, Metabolomics discloses donor liver biomarkers associated with early allograft dysfunction, J Hepatol, 61, 564, 10.1016/j.jhep.2014.04.023 Muthukumar, 2021, Serum MicroRNA transcriptomics and acute rejection or recurrent hepatitis C virus in human liver allograft recipients: a pilot study, Transplantation Shaked, 2017, An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection, Hepatology, 65, 269, 10.1002/hep.28786 Levitsky, 2022, Donor-derived cell-free DNA levels predict graft injury in liver transplant recipients, Am J Transplant, 22, 532, 10.1111/ajt.16835 Goh, 2019, The measurement of donor-specific cell-free DNA identifies recipients with biopsy-proven acute rejection requiring treatment after liver transplantation, Transplant Direct, 5, e462, 10.1097/TXD.0000000000000902 Schütz, 2017, Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: a prospective, observational, multicenter cohort study, PLoS Med, 14, 10.1371/journal.pmed.1002286 Zhao, 2021, Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients, Sci Rep, 11, 1138, 10.1038/s41598-020-80845-6 Cortes, 2017, Liver transplantation biomarkers in the metabolomics era, 99 Mohr, 2015, Overview of MicroRNA biology, Semin Liver Dis, 35, 3, 10.1055/s-0034-1397344 Hamdorf, 2017, The potential of MicroRNAs as novel biomarkers for transplant rejection, J Immunol Res, 2017, 4072364 Levitsky, 2020, Discovery and validation of a novel blood-based molecular biomarker of rejection following liver transplantation, Am J Transplant, 20, 2173, 10.1111/ajt.15953 Puliyanda, 2021, Donor-derived cell-free DNA (dd-cfDNA) for detection of allograft rejection in pediatric kidney transplants, Pediatr Transplant, 25, 10.1111/petr.13850 Knight, 2019, Donor-specific cell-free DNA as a biomarker in solid organ transplantation. A systematic review, Transplantation, 103, 273, 10.1097/TP.0000000000002482 Agbor-Enoh, 2021, Cell-free DNA to detect heart allograft acute rejection, Circulation, 143, 1184, 10.1161/CIRCULATIONAHA.120.049098 Chen, 2020, Urine donor–derived cell-free DNA helps discriminate BK polyomavirus-associated nephropathy in kidney transplant recipients with BK polyomavirus infection. Original research, Front Immunol, 11 Beck, 2013, Digital droplet PCR for rapid quantification of donor DNA in the circulation of transplant recipients as a potential universal biomarker of graft injury, Clin Chem, 59, 1732, 10.1373/clinchem.2013.210328 Grskovic, 2016, Validation of a clinical-grade Assay to measure donor-derived cell-free DNA in solid organ transplant recipients, J Mol Diagn, 18, 890, 10.1016/j.jmoldx.2016.07.003 Terasaki, 2006, Summary of the effect of de novo HLA antibodies on chronic kidney graft failure, Clin Transpl, 455 Min, 2010, Variability of gene expression profiles in human blood and lymphoblastoid cell lines, BMC Genom, 11, 96, 10.1186/1471-2164-11-96 Debey, 2006, A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials, Genomics, 87, 653, 10.1016/j.ygeno.2005.11.010 Roedder, 2011, Biomarkers in solid organ transplantation: establishing personalized transplantation medicine, Genome Med, 3, 37, 10.1186/gm253 McCaughan, 2018, Donor specific HLA antibodies & allograft injury: mechanisms, methods of detection, manifestations and management, Transpl Int, 31, 1059, 10.1111/tri.13324 Del Bello, 2016, Donor-specific antibodies and liver transplantation, Hum Immunol, 77, 1063, 10.1016/j.humimm.2016.02.006 Beyzaei, 2020, De novo donor specific antibody and long-term outcome after liver transplantation: a systematic review and meta-analysis, Front Immunol, 11, 613128, 10.3389/fimmu.2020.613128 Tambur, 2015, Assessing antibody strength: comparison of MFI, C1q, and titer information, Am J Transplant, 15, 2421, 10.1111/ajt.13295 Naini, 2013, Liver transplant pathology, Surg Pathol Clin, 6, 277, 10.1016/j.path.2013.03.004 Sanai, 2010, Liver biopsy for histological assessment: the case against, Saudi J Gastroenterol : Off J Saudi Gastroenterol Assoc, 16, 124, 10.4103/1319-3767.61244 Coffin, 2006, The impact of pathologist experience on liver transplant biopsy interpretation, Mod Pathol, 19, 832, 10.1038/modpathol.3800605 Halloran, 2006, Microarrays and transcriptome analysis in renal transplantation, Nat Clin Pract Nephrol, 2, 2, 10.1038/ncpneph0066 Madill-Thomsen, 2020, The molecular diagnosis of rejection in liver transplant biopsies: first results of the INTERLIVER study, Am J Transplant, 20, 2156, 10.1111/ajt.15828 Halloran, 2020, The Molecular Microscope(®) Diagnostic System meets eminence-based medicine: a clinician's perspective, Am J Transplant, 20, 2964, 10.1111/ajt.15940 Madill-Thomsen, 2017, The effect of cortex/medulla proportions on molecular diagnoses in kidney transplant biopsies: rejection and injury can Be assessed in medulla, Am J Transplant, 17, 2117, 10.1111/ajt.14233 Uo Uo Randhawa, 2020, The molecular microscope diagnostic system (MMDx) in transplantation: a pathologist's perspective, Am J Transplant, 20, 1965, 10.1111/ajt.15887 Halloran Halloran Halloran Halloran Madill-Thomsen, 2020, Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies, Am J Transplant, 20, 1341, 10.1111/ajt.15752 Adam, 2016, Multiplexed color-coded probe-based gene expression assessment for clinical molecular diagnostics in formalin-fixed paraffin-embedded human renal allograft tissue, Clin Transplant, 30, 295, 10.1111/ctr.12689 Feng, 2018, Evidence of chronic allograft injury in liver biopsies from long-term pediatric recipients of liver transplants, Gastroenterology, 155, 1838, 10.1053/j.gastro.2018.08.023 Mengel, 2020, Banff 2019 Meeting Report: molecular diagnostics in solid organ transplantation–Consensus for the Banff Human Organ Transplant (B-HOT) gene panel and open source multicenter validation, Am J Transplant, 20, 2305, 10.1111/ajt.16059 Smith, 2021, In-silico performance, validation, and modeling of the Nanostring Banff Human Organ transplant gene panel using archival data from human kidney transplants, BMC Med Genom, 14, 86, 10.1186/s12920-021-00891-5